BioSpace News Archive

A recent report by Transparency Market Research states that global telemedicine market is projected to witness a substantial growth from 2014 to 2020.

The global remote patient monitoring devices market is foreseen in a report by Transparency Market Research to show a decently consolidated nature coupled with intense competition between key players.

The global remote patient monitoring devices market is foreseen in a report by Transparency Market Research to show a decently consolidated nature coupled with intense competition between key players.

The global pain management devices market features an increasingly competitive landscape marked by rising level of competition among its players.

Respiratory diseases are on a rise and this is leading to growth in demand for medical oxygen concentrations market.

The global dental practice management software is anticipated to witness a remarkable growth in the coming years owing to the increasing number of dental problems as per the reports of the Transparency Market Research states.

T G4050 is being evaluated in two Phase 1 clinical trials. It combines Transgene’s proprietary myvac® platform with NEC’s cutting-edge Artificial Intelligence (AI) capabilities to select patient-specific neoantigens

Cybrexa Therapeutics, an oncology-focused biotechnology company developing a new class of therapeutics through its alphalex™ tumor targeting platform, announced that two posters featuring Cybrexa’s pipeline will be presented at the American Association for Cancer Research Virtual Annual Meeting II, which will be held June 22-24, 2020.

Orexo’s partner, Gesynta Pharma, announces positive phase I results for OX-MPI.

IDEAYA Biosciences, Inc. is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics.